Pro forma combined net loss $49.1M, diluted EPS ($0.66) for 2024 after Sherlock acquisition

ORASURE TECHNOLOGIES INC

Acquisition closed Dec 19, 2024; consideration includes $5M upfront, up to $20M milestones, and royalties.
Pro forma combined net loss $49.1M vs OraSure standalone net loss $19.5M for year ended Dec 31, 2024.
Pro forma diluted EPS ($0.66) vs standalone ($0.26) on 74.4M shares.
$17M in-process R&D intangible asset recognized for CT/NG test; goodwill $2.5M.
Contingent consideration fair value estimated at $22.9M ($15.9M milestone + royalties).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.